LSVVX
Price
$14.02
Change
+$0.13 (+0.94%)
Updated
Jun 26 closing price
Net Assets
128.18M
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

LSVVX vs RMEBX

Header iconLSVVX vs RMEBX Comparison
Open Charts LSVVX vs RMEBXBanner chart's image
LSV Conservative Value Equity
Price$14.02
Change+$0.13 (+0.94%)
VolumeN/A
Net Assets128.18M
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
LSVVX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LSVVX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSVVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. LSVVX (128M). LSVVX pays higher dividends than RMEBX: LSVVX (2.16) vs RMEBX (1.16). LSVVX was incepted earlier than RMEBX: LSVVX (18 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than LSVVX (0.56). RMEBX is a more actively managed with annual turnover of: 31.00 vs. LSVVX (9.00). RMEBX has a lower initial minimum investment than LSVVX: RMEBX (250) vs LSVVX (100000). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. LSVVX (-0.52). LSVVX return over 5 years is better than : 71.51 vs. RMEBX (62.71).
LSVVXRMEBXLSVVX / RMEBX
Total Expense Ratio0.351.0733%
Annual Report Gross Expense Ratio0.561.0752%
Fund Existence18 years11 years-
Gain YTD3.4257.31547%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets128M106B0%
Annual Yield % from dividends2.161.16186%
Returns for 1 year-0.529.50-5%
Returns for 3 years18.1025.8870%
Returns for 5 years71.5162.71114%
Returns for 10 years61.7874.5183%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp